Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Bcca - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Qeii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Royal Victoria Regional Health Centre
Barrie, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
- Algoma District Cancer Program
Sault Ste. Marie, Ontario, Canada
- Odette Cancer Centre
Toronto, Ontario, Canada
- University Health Network
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Hopital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Hopital de la Cite-de-la-Sante
Laval, Quebec, Canada
- L'Hotel-Dieu de Levis
Lévis, Quebec, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Centre Integre Universitaire de Sante Et de Services
Montreal, Quebec, Canada
- the Jewish General Hospital
Montreal, Quebec, Canada
- Chuq-Pavillon Hotel-Dieu de Quebec
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
- Centre Hospitalier Regional de Trois-Rivieres
Trois-Rivières, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Oct 2016
- Primary completion
- 18 Oct 2018
- Completion
- 7 Jun 2022
- Last update posted
- 8 Dec 2023
- Registered enrollment
- 180
- Registry id
- NCT02870920
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.